The DRUGMATRIX assay, which is used to test the effectiveness of drugs, focuses specifically on inhibiting the Carbonic Anhydrase II enzyme. The substrate used in the test is 4-Nitrophenyl acetate (4-NPA), and the assay is classified as a Direct single protein target assigned test. The test utilizes erythrocyte cells from humans and is conducted in a controlled laboratory setting (In vitro). This assay is designed to measure the binding properties of the drug being tested to the Carbonic Anhydrase II enzyme. Does this molecule show effectiveness in this assay?